Document ID: chunk:federal_register_of_legislation:F2017C00864:reg:8:p2
Version: federal_register_of_legislation:F2017C00864
Segment Type: reg
Provision Reference: reg 8 (pt 2/2)
Character Range: 7960–8702

the clinical worsening of optochiasmatic arachnoiditis;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(15)      having sarcoidosis or multiple sclerosis, involving inflammation of the leptomeninges surrounding the optic chiasm, before the clinical worsening of optochiasmatic arachnoiditis;
Note: leptomeninges is defined in the Schedule 1 - Dictionary.
(16)      having an intrathecal myelogram or intrathecal treatment with a substance from the specified list of substances before the clinical worsening of optochiasmatic arachnoiditis;
Note: specified list of substances is defined in the Schedule 1 - Dictionary.
(17)      inability to obtain appropriate clinical management for optochiasmatic arachnoiditis.